Molecular and phenotypic analysis of poorly differentiated sinonasal neoplasms: an integrated approach for early diagnosis and classification

Human Pathology

Volumn 40, Issue 3, 2009, Pages 283-292

  Cordes, Brett ^a   Williams, Michelle D ^b   Tirado, Yamilet ^a   Bell, Diana ^b   Rosenthal, David I ^b   Al Dhahri, Saleh F ^c   Hanna, Ehab Y ^b   El Naggar, Adel K ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c KING FAHAD MEDICAL CITY   (Saudi Arabia)

Author keywords

"Small round cell" neoplasms; Diagnostic profiling; Molecular classification; Poorly differentiated; Sinonasal tumors

Indexed keywords

CD56 ANTIGEN; CD99 ANTIGEN; CHROMOGRANIN; CYTOKERATIN 7; DESMIN; MELAN A; MESSENGER RNA; MONOPHENOL MONOOXYGENASE; MYOGENIN; PROTEIN P63; PROTEIN S 100; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR MASH1;

ARTICLE; CONTROLLED STUDY; DISEASE MARKER; EARLY DIAGNOSIS; EPITHELIUM; EWING SARCOMA; EWS FLI1 GENE; FUSION GENE; HISTOGENESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MELANOCYTE; MELANOMA; MESENCHYME CELL; NEUROBLASTOMA; NEUROECTODERM; NEUROENDOCRINE TUMOR; NEUROFILAMENT; PAX FKHR GENE; PHENOTYPE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; TISSUE MICROARRAY; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS; UNDIFFERENTIATED CARCINOMA;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARCINOMA, NEUROENDOCRINE; DNA, NEOPLASM; EARLY DETECTION OF CANCER; GENE EXPRESSION PROFILING; HUMANS; IMMUNOPHENOTYPING; MELANOMA; MOLECULAR DIAGNOSTIC TECHNIQUES; ONCOGENE PROTEINS, FUSION; PARANASAL SINUS NEOPLASMS; PARANASAL SINUSES; PROTO-ONCOGENE PROTEIN C-FLI-1; RHABDOMYOSARCOMA; RNA, NEOPLASM; SKULL BASE NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 59049106305     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.07.019     Document Type: Article

References (41)

1. Thompson L.D., Wieneke J.A., and Miettinen M. Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol 27 (2003) 594-611
2. Smith S.R., Som P., Fahmy A., Lawson W., Sacks S., and Brandwein M. A clinicopathological study of sinonasal neuroendocrine carcinoma and sinonasal undifferentiated carcinoma. Laryngoscope 110 (2000) 1617-1622
3. Iezzoni J.C., and Mills S.E. "Undifferentiated" small round cell tumors of the sinonasal tract: differential diagnosis update. Am J Clin Pathol 124 (2005) 110-121
4. Hicks J., and Flaitz C. Rhabdomyosarcoma of the head and neck in children. Oral Oncol 38 (2002) 450-459
5. Gaal K., Sun N.C., Hernandez A.M., and Arber D.A. Sinonasal NK/T-cell lymphomas in the United States. Am J Surg Pathol 24 (2000) 1511-1517
6. Ejaz A., and Wenig B.M. Sinonasal undifferentiated carcinoma: clinical and pathologic features and a discussion on classification, cellular differentiation, and differential diagnosis. Adv Anat Pathol 12 (2005) 134-143
7. Dockhorn-Dworniczak B., Schafer K.L., Dantcheva R., Blasius S., van Valen F., Burdach S., et al. Detection of EWS-/FLI-1 gene fusion transcripts by RT-PCR as a tool in the diagnosis of tumors of the Ewing sarcoma group. Verh Dtsch Ges Pathol 78 (1994) 214-219
8. Sorensen P.H., Lynch J.C., Qualman S.J., et al. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. J Clin Oncol 20 (2002) 2672-2679
9. Miettinen M., and Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 130 (2006) 1466-1478
10. Harrison M.L., and Goldstein D. Management of metastatic gastrointestinal stromal tumour in the Glivec era: a practical case-based approach. Intern Med J 36 (2006) 367-377
11. Fritsch M.K., Bridge J.A., Schuster A.E., Perlman E.J., and Argani P. Performance characteristics of a reverse transcriptase-polymerase chain reaction assay for the detection of tumor-specific fusion transcripts from archival tissue. Pediatr Dev Pathol 6 (2003) 43-53
12. Ferrari A., and Casanova M. Current chemotherapeutic strategies for rhabdomyosarcoma. Expert Rev Anticancer Ther 5 (2005) 283-294
13. Parham D.M. Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod Pathol 14 (2001) 506-514
14. Ladanyi M., Lewis R., Garin-Chesa P., et al. EWS rearrangement in Ewing's sarcoma and peripheral neuroectodermal tumor. Molecular detection and correlation with cytogenetic analysis and MIC2 expression. Diagn Mol Pathol 2 (1993) 141-146
15. Giovannini M., Biegel J.A., Serra M., et al. EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations. J Clin Invest 94 (1994) 489-496
16. Meier V.S., Kuhne T., Jundt G., and Gudat F. Molecular diagnosis of Ewing tumors: improved detection of EWS-FLI-1 and EWS-ERG chimeric transcripts and rapid determination of exon combinations. Diagn Mol Pathol 7 (1998) 29-35
17. Folpe A.L., Goldblum J.R., Rubin B.P., et al. Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases. Am J Surg Pathol 29 (2005) 1025-1033
18. Arvand A., and Denny C.T. Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene 20 (2001) 5747-5754
19. Qian X., Jin L., Shearer B.M., Ketterling R.P., Jalal S.M., and Lloyd R.V. Molecular diagnosis of Ewing's sarcoma/primitive neuroectodermal tumor in formalin-fixed paraffin-embedded tissues by RT-PCR and fluorescence in situ hybridization. Diagn Mol Pathol 14 (2005) 23-28
20. Mhawech-Fauceglia P., Herrmann F., Penetrante R., et al. Diagnostic utility of FLI-1 monoclonal antibody and dual-colour, break-apart probe fluorescence in situ (FISH) analysis in Ewing's sarcoma/primitive neuroectodermal tumour (EWS/PNET). A comparative study with CD99 and FLI-1 polyclonal antibodies. Histopathology 49 (2006) 569-575
21. Bridge R.S., Rajaram V., Dehner L.P., Pfeifer J.D., and Perry A. Molecular diagnosis of Ewing sarcoma/primitive neuroectodermal tumor in routinely processed tissue: a comparison of two FISH strategies and RT-PCR in malignant round cell tumors. Mod Pathol 19 (2006) 1-8
22. Hill D.A., O'Sullivan M.J., Zhu X., et al. Practical application of molecular genetic testing as an aid to the surgical pathologic diagnosis of sarcomas: a prospective study. Am J Surg Pathol 26 (2002) 965-977
23. Jiang S.X., Kameya T., Asamura H., et al. hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors. Mod Pathol 17 (2004) 222-229
24. Mhawech P., Berczy M., Assaly M., et al. Human achaete-scute homologue (hASH1) mRNA level as a diagnostic marker to distinguish esthesioneuroblastoma from poorly differentiated tumors arising in the sinonasal tract. Am J Clin Pathol 122 (2004) 100-105
25. Sippel R.S., Carpenter J.E., Kunnimalaiyaan M., and Chen H. The role of human achaete-scute homolog-1 in medullary thyroid cancer cells. Surgery 134 (2003) 866-871
26. Shida T., Furuya M., Nikaido T., et al. Aberrant expression of human achaete-scute homologue gene 1 in the gastrointestinal neuroendocrine carcinomas. Clin Cancer Res 11 (2005) 450-458
27. Stevenson A.J., Chatten J., Bertoni F., and Miettinen M. CD-99 (p30/p32 MIC-2) neuroectodermal/Ewing's sarcoma antigen as an immunohistochemical marker. Appl Immunohistochem 2 (1994) 231-234
28. Folpe A.L., Hill C.E., Parham D.M., O'Shea P.A., and Weiss S.W. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor. Am J Surg Pathol 24 (2000) 1657-1662
29. Ozdemirli M., Fanburg-Smith J.C., Hartmann D.P., Azumi N., and Miettinen M. Differentiating lymphoblastic lymphoma and Ewing's sarcoma: lymphocyte markers and gene rearrangement. Mod Pathol 14 (2001) 1175-1182
30. Montone K.T., Barr F.G., Feldman M.D., and LiVolsi V.A. Sinonasal rhabdomyosarcoma in adults: a report of 12 cases. Mod Pathol (2007) [Abstract]
31. Lee J.H., Kim S.H., Wang L.H., et al. Clinical significance of CD99 down-regulation in gastric adenocarcinoma. Clin Cancer Res 13 (2007) 2584-2591
32. Bahrami A., Gown A.M., Baird G.S., Hicks M.J., and Folpe A.L. Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall. Mod Pathol 21 (2008) 795-806
33. Molenaar W.M., and Muntinghe F.L. Expression of neural cell adhesion molecules and neurofilament protein isoforms in skeletal muscle tumors. Hum Pathol 29 (1998) 1290-1293
34. Dabbs D. Diagnostic immunohistochemistry (2006), Churchill, Livingstone, Philadelphia
35. Belchis D. Diagnostic immunohistochemistry of pediatric small cell tumors (2006), Churchill, Livingstone, Philadelphia
36. Ingeholm P., Theilgaard S.A., Buchwald C., Hansen H.S., and Francis D. Esthesioneuroblastoma: a Danish clinicopathological study of 40 consecutive cases. Apmis 110 (2002) 639-645
37. Hirose T., Scheithauer B.W., Lopes M.B., et al. Olfactory neuroblastoma. An immunohistochemical, ultrastructural, and flow cytometric study. Cancer 76 (1995) 4-19
38. Eyden B., Pandit D., and Banerjee S.S. Malignant melanoma with neuroendocrine differentiation: clinical, histological, immunohistochemical and ultrastructural features of three cases. Histopathology 47 (2005) 402-409
39. Liu Q., Ohshima K., Sumie A., Suzushima H., Iwasaki H., and Kikuchi M. Nasal CD56 positive small round cell tumors. Differential diagnosis of hematological, neurogenic, and myogenic neoplasms. Virchows Arch 438 (2001) 271-279
40. Rodriguez J., Romaguera J.E., Manning J., et al. Nasal-type T/NK lymphomas: a clinicopathologic study of 13 cases. Leuk Lymphoma 39 (2000) 139-144
41. Woog J.J., Kim Y.D., Yeatts R.P., et al. Natural killer/T-cell lymphoma with ocular and adnexal involvement. Ophthalmology 113 (2006) 140-147